CNBSAmplify Seymour Cannabis ETF
Seeks capital appreciation by investing in U.S. companies engaged in cannabis and hemp-related activities.
By Amplify ETFs · Launched 2019
Annual Cost
0.76%
#4,041 of 5,854 · expensive
Fund Size
$84M
#3,153 of 5,854 · mid-size
Return (1Y)Goal
+35.3%
Track Record
7 years
#1,900 of 5,854 · established
Performance
Total-return NAV · USDGrowth of $10,000
$13,227+32.3%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 98.9% of fundconcentrated
TREASURY BILL
51.8%
TREASURY BILL
25.1%
Curaleaf Holdings Inc
12.7%
Innovative Industrial Properti
3.2%
TREASURY BILL
1.6%
WM Technology Inc
1.5%
GrowGeneration Corp
1.0%
TREASURY BILL
0.9%
Chicago Atlantic Real Estate F
0.6%
N/A
0.6%
Asset allocation
Stocks
90.2%
Other
13.2%
By sector
Healthcare
63.1%
Real Estate
13.8%
Technology
10.7%
Consumer Defensive
7.0%
Consumer Cyclical
3.4%
Financial Services
1.9%
Industrials
0.1%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
104.8%High
Year-on-year price swings
Max drawdown
-95.7%Severe
Worst peak-to-trough loss
Sharpe (3Y)
0.22Below average
Sortino (3Y)
0.37Moderate downside risk
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks capital appreciation by investing in U.S. companies engaged in cannabis and hemp-related activities.
- Strategy
- Actively manages a portfolio of U.S. companies engaged in cannabis and hemp-related activities, investing primarily in securities that derive significant revenue from this ecosystem. Focuses on small, medium, and large capitalization companies to achieve capital appreciation.
- Inception date
- July 15, 2019
- Fund family
- Amplify ETFs
Similar funds
Same asset class, closest by strategy & exposureWhat's next?
You've looked at CNBS. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-08-03